Defective synapse maturation and enhanced synaptic plasticity in Shank2 Δex7(-/-) mice by Wegener, S. et al.
Disorders of the Nervous System
Defective Synapse Maturation and Enhanced
Synaptic Plasticity in Shank2 ex7–/– Mice
Stephanie Wegener,1 Arne Buschler,2 A. Vanessa Stempel,1 Sukjae J. Kang,3 Chae-Seok Lim,3
Bong-Kiun Kaang,3 Sarah A. Shoichet,4 Denise Manahan-Vaughan,2 and Dietmar Schmitz5
DOI:http://dx.doi.org/10.1523/ENEURO.0398-17.2018
1Neuroscience Research Center, Charité Universitätsmedizin, 10117 Berlin, Germany, 2Medical Faculty, Department
of Neurophysiology, Ruhr University Bochum, 44801 Bochum, Germany, 3School of Biological Sciences, Seoul
National University, Seoul 08826, Korea, 4Institute of Biochemistry and Cluster of Excellence NeuroCure, Charité
Universitätsmedizin, 10117 Berlin, Germany, and 5Neuroscience Research Center, Cluster of Excellence NeuroCure,
German Center for Neurodegenerative Diseases, Charité Universitätsmedizin, 10117 Berlin, Germany
Visual Abstract
Autism spectrum disorders (ASDs) are neurodevelopmental disorders with a strong
genetic etiology. Since mutations in human SHANK genes have been found in patients
with autism, genetic mouse models are used for a mechanistic understanding of ASDs
and the development of therapeutic strategies. SHANKs are scaffold proteins in the
postsynaptic density of mammalian excitatory synapses with proposed functions in
synaptogenesis, regulation of dendritic spine morphology, and instruction of structural
synaptic plasticity. In contrast to all studies so far on the function of SHANKproteins,we
have previously observed enhanced synaptic plasticity in Shank2 ex7/ mice. In a
series of experiments, we now reproduce these results, further explore the synaptic
phenotype, and directly compare our model to the independently generated Shank2
ex6-7/ mice. Minimal stimulation experiments reveal that Shank2 ex7/ mice
possess an excessive fraction of silent (i.e., -amino-3-hydroxy-5-methyl-4-isoxa-
zolepropionic acid, short, AMPA receptor lacking) synapses. The synaptic maturation
deficit emerges during the third postnatal week and constitutes a plausible mechanistic
explanation for the mutants’ increased capacity for long-term potentiation, both in vivo
and in vitro. A direct comparison with Shank2 ex6-7/ mice adds weight to the
hypothesis that both mouse models show a different set of synaptic phenotypes,
possibly due to differences in their genetic background. These findings add to the
diversity of synaptic phenotypes in neurodevelopmental disorders and further support
the supposed existence of “modifier genes” in the expression and inheritance of ASDs.
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Significance Statement
Autism spectrum disorders have a global prevalence of 0.1–2%, a fraction of which is caused bymutations in human
SHANK genes. A number of Shankmousemodels that reproduce behavioral symptoms also show reduced synaptic
plasticity, which is why boosting plasticity has become one line of therapeutic rescue efforts. In contrast to all studies
so far on the function of SHANK proteins, we observe enhanced plasticity in Shank2 ex7/ mice and uncover a
previously unrecognized synapsematuration deficit. This neurodevelopmental phenotype is shared among a number
of mouse models for neurodevelopmental disorders, suggesting synapse maturation as a field of future studies and
for the exploration of therapeutic intervention. The observation of distinct and noncongruent phenotypes in genetically
similar yet nonidentical mouse models adds weight to the hypothesis that genetic interactions of putative “modifier
genes” might influence the phenotype.
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Introduction
The activity-dependent formation and remodeling of
synaptic connections is pivotal to adaptive neural circuit
function. Dysregulation of these processes is considered
a prime cause of neurodevelopmental diseases such as
autism spectrum disorders (ASDs; Ebert and Greenberg,
2013). The list of mutations associated with ASDs and the
number of mouse models is growing rapidly, yet under-
standing the connections among genetic mutation, synaptic
defects, and disease phenotypes remains a challenge.
Mutations in all three SHANK genes (SHANK1, SHANK2,
and SHANK3) occur in autistic patients (Durand et al.,
2007; Berkel et al., 2010; Sato et al., 2012), and Shank
mutant mice reproduce several autism-related pheno-
types (Bozdagi et al., 2010; Peça et al., 2011; Wang et al.,
2011; Schmeisser et al., 2012; Won et al., 2012; Lee et al.,
2015; Peter et al., 2016). SHANKs (short for SH3 and
multiple ankyrin repeat domains protein, also referred to
as ProSAPs) are scaffold proteins in the postsynaptic
density of mammalian excitatory synapses, linking post-
synaptic membrane proteins to the cytoskeleton (for re-
view, see Sheng and Kim, 2000) to serve functions in
synaptogenesis (Du et al., 1998; Roussignol et al., 2005),
regulation of dendritic spine morphology (Sala et al.,
2001; Haeckel et al., 2008; Kim et al., 2009; Verpelli et al.,
2011; Durand et al., 2012), and instruction of structural
synaptic plasticity (MacGillavry et al., 2016).
Considerable efforts have been made to understand
and differentiate the roles of different Shank isoforms in
synaptic function and ASD pathophysiology (for review,
see Jiang and Ehlers, 2013). The picture is complicated by
diverging reports on the synaptic pathophysiology of mice
lacking Shank2: for two independently generated Shank2
knock-out (KO) mice, noncongruent results on long-term
plasticity and excitatory synaptic transmission were re-
ported in two independent studies (Shank2 ex7/,
Schmeisser et al., 2012; Shank2 ex6-7/, Won et al.,
2012), and differences in inhibitory synaptic transmission
were found in a direct comparison of the two mouse
models (Lim et al., 2017).
To consolidate and mechanistically advance our under-
standing of excitatory synaptic transmission in Shank2
knock-out mice, we here report robustly increased long-
term potentiation (LTP) in Shank2 ex7/ mice upon
electric stimulation in vitro and also in vivo. We find that
Shank2 ex7/ mice suffer from deficient synaptic mat-
uration and an increased fraction of AMPA receptor-
lacking synapses, suggesting a mechanistic explanation
for their increased LTP capacity. A direct comparison of in
vivo LTP in Shank2 ex6-7/ and Shank2 ex7/ mice
reveals further differences between the two mouse mod-
els, supporting the idea of genetic interactions in the
Shank2 mouse model (Lim et al., 2017), paralleling obser-
vations of putative modifier genes in the expression and
inheritance of ASDs (Leblond et al., 2012).
Materials and Methods
Shank2 ex7 (Schmeisser et al., 2012) and Shank2
ex6-7 mice (Won et al., 2012) were bred on a C57BL/6J
background with a heterozygous breeding protocol. The
study was conducted in accordance with the European
Communities Council Directive of September 22, 2010
(2010/63/EU) for care of laboratory animals and after
approval by the local ethics and/or animal welfare com-
mittees [Berlin animal experiment authorities and the
Animal Welfare Committee of the Charité Berlin (File ref-
erence: T100/03), and Landesamt für Naturschutz, Ver-
braucherschutz und Umweltschutz, Nordrhein Westfalen,
respectively]. Wild-type littermates were used as a control
throughout, and experimenters were blind to the geno-
type of the tested animals for data collection and analysis.
Hippocampal brain slices were prepared from animals
of both sexes as described previously (Schmeisser et al.,
2012). Briefly, mice were anesthetized with isoflurane and
decapitated. Brains were rapidly removed and transferred
to ice-cold ACSF slicing solution. The ACSF slicing solu-
tion contained the following (in mM): 87 NaCl, 26 NaHCO3,
50 sucrose, 25 glucose, 3 MgCl2, 2.5 KCl, 1.25 NaH2PO4,
and 0.5 CaCl2. The ACSF recording solution contained
the following (in mM): 119 NaCl, 26 NaHCO3, 10 glucose,
2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, and 1 NaH2PO4. All ACSF
was equilibrated with carbogen (95% O2, 5% CO2). Tis-
sue blocks containing the hippocampus were mounted on
a Vibratome (VT1200, Leica) and cut into horizontal slices
of 300 m. For submerged slice storage (used for minimal
stimulation experiments), slices were, after preparation,
kept submerged in ACSF at 34°C for 30 min, then slowly
cooled to room temperature where they were left to re-
cover for at least 30 min up to 5 h. Recordings were
performed in slices submerged in ACSF and at room tem-
perature. For a subset of experiments (Fig. 1), we repro-
duced a range of conditions from the study by Won et al.
(2012): immediately after preparation, slices were trans-
ferred into an ACSF/oxygenated air interface chamber
and allowed to remain there to recover until recording, for
at least 1 h and at most 5 h. Recordings were performed
in a submerged recording chamber; the storage and re-
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cording temperature for these experiments was 34°C.
Mouse age for in vitro experiments was 8-9 weeks for the
experiments shown in Figure 1A and 3–4 weeks for ex-
periments in Figure 1D and Figure 4A–D. For the remain-
ing in vitro experiments (Figs. 1B,C, 4E), mouse age is
indicated in the figure legend.
For all in vitro experiments, data were recorded with an
Axopatch 700A Amplifier (Molecular Devices), digitized at
5 kHz, filtered at 2 kHz, and recorded in IGOR Pro 4.0.
Evoked postsynaptic responses were induced by stimulat-
ing Schaffer collaterals in CA1 stratum radiatum. Field
EPSPs (fEPSPs) were recorded in stratum radiatum.
fEPSP rising slopes were fitted to 20–80% of the fEPSP
amplitude. LTP was induced by a single tetanus of 100
pulses at 100 Hz. For whole-cell patch-clamp recordings,
the recording ACSF was supplemented with 1 M gaba-
zine. Pipettes had resistances of 2–3 M. Liquid junction
potential was not corrected. Series resistance (not com-
pensated) was constantly monitored and was not allowed
to increase beyond 22 M or change by20% during the
experiment. Compound EPSCs were recorded at 60
and 40 mV with a cesium-based intracellular recording
solution containing the following (in mM): 145 CsCl, 10
HEPES, 0.2 EGTA, 2 MgCl2, 2 NaATP, 0.5 NaGTP, and 5
phosphocreatine, with osmolarity of 305 mOsm and pH
adjusted to 7.2 with CsOH. The AMPA receptor-mediated
component of the EPSC was estimated by measuring the
peak amplitude of the averaged EPSC at 60 mV. The
N-methyl-D-aspartate, short, NMDA receptor-mediated
component was estimated at 40 mV by measuring the
amplitude of the averaged EPSC 25 ms after stimulation.
Figure 1. Enhanced LTP and reduced basal transmission in Shank2 ex7/mice in vitro. A, Enhanced LTP in Shank2 ex7/mice
in vitro. NMDA receptor-dependent LTP in the CA1 region of corticohippocampal slices was induced by high-frequency stimulation
protocol (HFS; closed symbols). In a subset of experiments (/, 5/10; –/–, 7/9), synaptic responses of a nonpotentiated fiber tract
were recorded as an additional control (control; open symbols). Example traces at top. p  0.0025 [difference between genotypes
in a two-way ANOVA; n(N)/  10(3), n(N)/  9(3)]. Slices were stored in an ACSF/oxygenized air interface chamber as reported
by Won et al. (2012). B, Increased LTP in Shank2 ex7/ mice is irrespective of animal age and slice storage. Submerged data
replotted from Schmeisser et al. (2012). Significance was tested with two-way ANOVA p 0.0001 for genotype comparison across
conditions. C, Decreased basal synaptic transmission in Shank2 ex7/mice irrespective of animal age and slice storage. Basal transmission
for each experiment is expressed as a single slope fitted to the input–output function of fEPSP slope vs fiber volley. Slopes of each group are
normalized to the population mean of the wild type in the respective recording condition. Submerged data (P25) from the study by Schmeisser
et al. (2012) are reanalyzed. Significance was tested with two-way ANOVA. p 0.0005 for genotype comparison across conditions.D, Slice
storage conditions affect AMPA/NMDA receptor ratios. Significance was tested with Mann–Whitney U test. AMPA/NMDA receptor ratios
are significantly reduced in CA1 pyramidal cells of Shank2 ex7/ mice when slices are stored submerged in ACSF before recording
[submerged 1: p 0.013 data replotted from the study by Schmeisser et al., 2012; submerged 2: p 0.036; see also Fig. 4B], but not when
stored in an ACSF/oxygenated air interface chamber. Mouse age was 3-4 weeks for all groups.
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For minimal stimulation, the stimulation frequency was
0.2 Hz, and the stimulation electrode was placed to pro-
duce a single-peak response. At 40 mV holding poten-
tial, stimulation intensity was reduced until transmission
failures were observed (in 	10–40% of events), and
20–50 events were recorded. Cells were subsequently
clamped to 60 mV holding potential, and 30–50 events
were recorded at the same stimulation intensity. In a subset
of experiments, this order was reversed [i.e., stimulation
intensity was adjusted and miniature EPSCs (minEPSCs)
were recorded at 60 mV first, before cells were clamped
to 40 mV]. We did not observe systematic differences in
failure rates (rf) or amplitudes of minEPSCs between the
two regimes. Experiments with linearly increasing or de-
creasing failure rates and/or minEPSCs amplitudes at any
holding potential were excluded from the analysis. Post
hoc analysis counted a failure at depolarized potentials
whenever the minEPSCs charge 5–40 ms after stimula-
tion did not exceed a threshold of 0.9 pC. Failures at
hyperpolarized potentials were defined as events with an
minEPSCs peak smaller than twice the signal noise (i.e.,
the SD of the signal in a 3 ms time window averaged over
all sweeps at a certain holding potential) of that recording.
The average signal noise was not different among exper-
imental groups, and experiments with high background
noise were excluded from the analysis. While the absolute
failure rates depended on how the criteria for failure ver-
sus successes were set, the relative difference between
genotypes did not. For each experiment, the synaptic
potency was defined as the average amplitude of all
minEPSCs at a given holding potential that qualified as
successes. For EPSCs recorded at 60 mV, the ampli-
tude was taken at the peak of all individual EPSCs after
subtraction of the average failure (for removal of the stim-
ulus artifact). For EPSCs recorded at 40 mV, the ampli-
tude was read 25 ms after stimulation. Synaptic
transmission under minimal stimulation can be described
by a Poisson distribution: Pk mkem/k! with Pk being
the probability of k quanta being released and m being the
mean quantal content. Since the failure rate rf P0 em,
the fraction of silent synapses can be estimated as 1 
lnrf 60mV  rf 40mV (Liao et al., 1995) and the synaptic
potency S   ln rf * q, with q being the mean quantal
size.
For in vivo experiments, 7- to 8-week-old male mice
were implanted (under anesthesia) with a stimulation elec-
trode in the Schaffer collaterals (2.0 mm posterior and 2.0
mm lateral to bregma) and a recording electrode in the
stratum radiatum of the dorsal CA1 region (1.9 mm pos-
terior and 1.4 mm lateral to bregma), as described previ-
ously (Buschler et al., 2012). Animals recovered for 	10 d
before experiments were commenced. Before each ex-
periment, input/output (I/O) properties were recorded by
increasing the stimulation intensity stepwise (Fig. 2C).
Experiments were conducted in recording chambers [20
(length) 
 20 (width) 
 30 (height) cm] where animals
could move freely and had access to food and water ad
libitum. During recordings, implanted electrodes were
connected via a flexible cable and a rotatable commutator
to the stimulation unit and amplifier. Test-pulse stimula-
tion was set to elicit 40% of the maximal I/O response.
Stimuli of 0.2 ms duration were applied at a frequency of
0.025 Hz and recorded with a sample rate of 10 kHz.
Different protocols were used to elicit LTPs of differing
magnitudes and durations (Buschler et al., 2012), all
NMDA receptor dependent (Ballesteros et al., 2016). Two
induction protocols were found to elicit robust LTP that
was stable for 3 h (3h-LTP). Protocol 1 contained four
trains of 50 pulses at 100 Hz with a 5 min intertrain interval
(Shank2 ex7: N/  N/  8; Shank2 ex6-7: N/ 
N/  5). Protocol 2 contained 2 trains of 50 pulses at
200 Hz with 5 min intertrain interval (Shank2 ex7: N/ 
8, N/  7; Shank2 ex6-7: N/  N/  5). Results
from both protocols were quantitatively similar and
pooled for Figures 2A and 3A , respectively. Two proto-
cols elicited LTP that was short lived, receding back to
baseline in 	2 h (2h-LTP): protocol 3, a single train of 50
pulses at 100 Hz stimulation (Shank2 ex7: N/  N/ 
Figure 2. Enhanced LTP and reduced basal transmission in Shank2 ex7/ mice in vivo. A, Enhanced LTP in Shank2 ex7/ mice
in vivo. 3h-LTP was induced at time point “0” by high-frequency stimulation in awake, freely behaving mice (for details, see Materials
and Methods). Example traces are at top. LTP was induced in both genotypes (ANOVA; : /: p  0.017, N  16; /: p  0.0001,
N  15) but was significantly larger in Shank2 ex7/ mice (p  0.0001, difference between genotypes in a two-way ANOVA).
B, 2h-LTP was induced by mild high-frequency stimulation in awake, behaving mice (for details, see Materials and Methods).
Significance was tested with two-way ANOVA. LTP was induced in both genotypes (: /, p  0.0001, N  16; /, p  0.0019,
N  16) with no significant difference between genotypes. C, Basal synaptic transmission in awake, behaving mice is reduced in
Shank2 ex7/ mice compared with wild-type controls. p  0.011 (difference between genotypes in a two-way ANOVA; N/ 
12; N/  8).
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8; Shank2 ex6-7: N/  N/  5); and protocol 4, two
trains of 50 pulses at 100 Hz stimulation with a 5 min
intertrain interval (Shank2 ex7: N/  N/  8; Shank2
ex6-7: N/  N/  5). Results from protocols 3 and
4 were quantitatively similar and pooled for Figures 2B
and 3B, respectively. Statistical tests for the expression of
LTP within an experimental group involved comparing
post-tetanus responses to pretetanus baseline responses
with time as a continuous variable (with all time points
before induction set to 0 min) and preinduction/postin-
duction as a categorical variable. Tests between geno-
types compared postinduction time points only, with time
as a continuous variable and genotype as a categorical
variable. Potentiation in text and Table 1 was quantified at
2–3 h postinduction for 3h-LTP and 1–2 h postinduction
for 2h-LTP.
Analyses were performed using custom-written proce-
dures in IGOR Pro and MATLAB. Data in graphs and text
are, unless stated otherwise, presented as the mean SE
for parametric data and the median [25th 75th percentile]
for nonparametric data (graphically, whiskers additionally
represent the minimum and maximum values). Unpaired
two-tailed Student’s t test (short: Student’s t test) and
ANOVAs were used to test for the statistical significance
of parametric data, and Mann–Whitney U tests and
Kruskal–Wallis tests were used for nonparametric data.
Results were considered to be significant at p  0.05.
Curve fitting was performed in MATLAB using a nonlinear
least-squares algorithm. Stimulus artifacts were blanked
or cropped in sample traces. Sample sizes are given as
the number of experiments and the number of animals (N).
Results
Two parallel studies on genetically similar Shank2/
mice have reported increased LTP (Schmeisser et al.,
2012) and decreased LTP (Won et al., 2012), respectively,
in hippocampal brain slices of Shank2-null mutants. To
investigate whether biological or methodological differ-
ences account for this discrepancy, we first investigated
in Shank2 ex7/ mice (Schmeisser et al., 2012) how
differences in slice storage, recording temperature, and
animal age might affect the expression of LTP. To this
end, we reproduced a range of conditions from the study
by Won et al. [2012; i.e., slices were stored in an ACSF/
oxygenated air (Haas type) interface chamber instead of
submerged in ACSF before recording; animal age was
8–9 weeks instead of 3–4 weeks, and recordings were
performed at elevated temperature instead of room tem-
perature]. Hippocampal slices from Shank2 ex7/mice
were then subjected to the common LTP induction protocol
(for details, seeMaterials andMethods). In our hands, also in
these conditions, Shank2 ex7/ mice showed markedly
higher LTP than wild-type controls [WT, 38 9%; KO, 76
6%; N/  10(3); N/  9(3); Fig. 1A].
Since the studies on Shank2 ex7/ and Shank2
ex6-7/ mice also reported different phenotypes with
respect to excitatory basal synaptic transmission and syn-
aptic AMPA/NMDA ratios, we assessed these physiologic
parameters as well. A quantitative comparison between
results from the previous study (Schmeisser et al., 2012)
and new experiments is presented in Figure 1B–D. Slice
storage affected phenotypes to varying degrees: While in
our hands storing slices submerged in ACSF versus a
Haas-type interface chamber before recording had no
effect on the expression of LTP (p  0.89 for comparison
of experimental conditions in a two-way ANOVA; Fig. 1B)
or basal synaptic transmission (p  0.98 for comparison
of experimental conditions in a two-way ANOVA; Fig. 1C),
it did affect AMPA/NMDA receptor ratios (Fig. 1D), with a
trend toward an increased AMPA/NMDA ratio in slices of
Shank2 ex7/ mice that have been stored in an inter-
face chamber (Mann–Whitney U test, p 0.29) compared
with significantly reduced AMPA/NMDA ratio in slices that
have been stored in submerged conditions (Mann–Whit-
ney U test, p  0.013 and p  0.036 for two independent
datasets; Fig. 1D). Increased AMPA/NMDA ratios have
been reported in Shank2 ex6-7/ mice (Won et al.,
2012); we thus conclude that the experimental conditions
examined here might explain some diverging results in
Shank2 ex7/ versus Shank2 ex6-7/ mice, like
AMPA/NMDA ratios, but not the contrary observations on
basal synaptic transmission and LTP.
Figure 3. In vivo LTP in Shank2 ex6-7/ mice. A, High-frequency stimulation at time point “0” successfully induced 3h-LTP in
Shank2 ex6-7/ and wild-type mice (: /, p  0.0001, N  10; /, p  0.012, N  10) with no detectable difference between
genotypes. Significance was tested by two-way ANOVA. B, 2h-LTP was successfully induced in both genotypes (;/, p 0.0001,
N  10; /, p  0.001, N  10). A trend for reduced potentiation in Shank2 ex6-7/ mice did not reach significance (p  0.16,
difference between genotypes in a two-way ANOVA). C, Basal synaptic transmission in awake, behaving mice is not significantly
different in Shank2 ex6-7/mice compared with wild-type controls (p 0.94, difference between genotypes in a two-way ANOVA;
N/  N/  5).
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In light of these results and reports on substantial
changes in synaptic spine morphology after brain slice
preparation (Kirov et al., 1999), we reasoned that an in
vitro examination of Shank2/ phenotypes might be
problematic, given that SHANK2 has a well described role
in synaptogenesis and the regulation of structural dynam-
ics in dendritic spines (MacGillavry et al., 2016). More
precisely, we still wondered whether the decreased basal
synaptic transmission and increased LTP we consistently
observed in Shank2 ex7/ mice might be secondary to
slicing-induced synaptic remodeling. This motivated us to
examine synaptic transmission and NMDA receptor-
dependent LTP in vivo. Using established experimental
procedures (Buschler et al., 2012; for details, see Materi-
als and Methods), we compared Shank2 ex7/ and
wild-type mice with regard to their capacity to express
LTP in vivo. We tested different induction protocols, elic-
iting both short- and long-lasting forms of LTP in freely
behaving mice (Buschler et al., 2012), from here on re-
ferred to as 2h-LTP and 3h-LTP, respectively (for details,
see Materials and Methods). Both forms of LTP could be
elicited in Shank2 ex7/ mice and wild-type controls
(Fig. 2A,B), validating that synapses without SHANK2 can
express LTP, as our data from acute slices suggest. For
3h-LTP, the potentiation in Shank2 ex7/ mice signifi-
cantly exceeded that of wild-type controls [WT, 9  4%
Table 1. Details of statistical analyses presented in the article
Figures Experiment n(N) Test used p value Mean (CI)
1A In vitro, interface, P55 WT: 10(3), KO: 9(3) ANOVA 0.0025 see 1Bleft
1B Left: in vitro, interface, P55 WT: 10(3), KO: 9(3) Two-way ANOVA Experimental condition: 0.89
genotype: 0.0001
WT: 38.3 (18.2), KO: 76.4 (12.0)
Right: in vitro,
submerged, P25
WT: 30(5), KO: 34(6) WT: 37.6 (6.1),
KO: 56.3 (6.9)
1C Left: in vitro,
interface, P25
WT: 4(2), KO: 4(2) Two-way ANOVA Experimental condition: 0.98
genotype: 0.0005
WT: 1.00 (0.31), KO: 0.67 (0.29)
Middle: in vitro, submerged,
P25
WT: 8(3), KO: 11(4) WT: 1.00 (0.24), KO: 0.71 (0.14)
Right: in vitro,
interface, P85
WT: 9(3), KO: 9(3) WT: 1.00 (0.20),
KO: 0.69 (0.12)
1D Left: in vitro, submerged, P25 WT: 18(8), KO: 19(6) Mann–Whitney U 0.013 WT: 1.0 [0.8 1.4], KO: 0.7 [0.6 0.9]
Middle: in vitro, submerged, P25 WT: 20(6), KO: 18(8) Mann–Whitney U 0.036 WT: 1.0 [0.6 1.2], KO: 0.5 [0.4 1.1]
Right: in vitro,
interface, P25
WT: 12(2), KO: 12(2) Mann–Whitney U 0.29 WT: 1.0 [0.5 1.3], KO: 1.2 [0.7 1.7]
2A In vivo, P50, 3h-LTP WT: 16, KO: 15 For LTP induction: two-way
ANOVA
LTP (categorical): WT: 0.017,
KO: 0.0001
time (continuous): WT: 0.42,
KO: 0.005
LTP 2-3h postinduction (%):
WT: 9.1 (8.6), KO: 32.6 (25.5)
Between genotypes:
two-way ANOVA
genotype: 0.0001
time: 0.016
2B In vivo, P50, 2h-LTP WT: 16, KO: 16 For LTP induction: two-way
ANOVA
LTP (categorical): WT: 0.0001,
KO: 0.002
time (continuous): WT: 0.02,
KO: 0.15
LTP 1-2h postinduction (%):
WT: 15.0 (6.9), KO: 15.0 (12.1)
Between genotypes:
two-way ANOVA
Genotype: 0.82
time: 0.048
2C In vivo, P50 WT: 12, KO: 8 Two-way ANOVA Genotype: 0.011
stimulation: 0.0001
WT125A: 1.9 (1.1),
KO125A: 1.1 (0.5)
3A In vivo, P50, L-LTP WT: 10, KO: 10 For LTP induction: two-way
ANOVA
LTP (categorical): WT: 0.0001,
KO: 0.012
time (continuous): WT: 0.007,
KO: 0.74
LTP 2-3h postinduction (%):
WT: 12.9 (11.2), KO: 14.3 (12.0)
Between genotypes:
two-way ANOVA
Genotype: 0.79
time: 0.17
3B In vivo, P50, E-LTP WT: 10, KO: 10 For LTP induction: two-way
ANOVA
LTP (categorical): WT: 0.0002,
KO: 0.0001
time (continuous): WT: 0.022,
KO: 0.003
LTP 1-2h postinduction (%):
WT: 12.0 (18.6), KO: 10.6 (13.2)
Between genotypes:
two-way ANOVA
Genotype: 0.16
time: 0.006
3C In vivo, P50 WT: 5, KO: 5 Two-way ANOVA Genotype: 0.94
stimulation: 0.0001
WT125A: 2.2 (1.9), KO125A:
1.7 (1.4)
4A In vitro, submerged, P25 WT: 11(6) Student’s t test (paired) WT: 0.19 WT60mV: 16.3 (6.6), WT40mV:
13.2 (5.6)
KO: 14(6) Student’s t test (paired) KO: 0.0003 KO60mV: 36.3 (10.9),
KO40mV: 12.7 (4.1)
4C In vitro, submerged, P25 WT: 11(6), KO: 13(6) Student’s t test 0.0018 WT: 3.1 (4.4), KO: 23.6 (9.4)
4D In vitro, submerged, P25 WT: 20(6), KO: 18(8) Mann–Whitney U 0.036 WT: 1.9 [1.1 2.3], KO: 0.9 [0.7 2.0]
4E In vitro, submerged,
AMPA/NMDA ratio
P13–P14: WT: 16(4)
KO: 18(5)
P21–P24: WT: 10(3),
KO: 11(3)
P25–P28: WT: 10(4),
KO: 7(3)
Over age groups:
Kruskal–Wallis test
WT: 0.0026, KO: 0.056 P13–P14: WT: 0.68 [0.47 0.88],
KO: 0.45 [0.31 0.64]
P21–P24: WT: 0.75 [0.55 1.09],
KO: 0.63 [0.43 0.93]
P25–P28: WT: 1.20 [0.88 1.48],
KO: 0.78 [0.50 1.00]
Between genotypes:
Mann–Whitney U
P13–P14: 0.055
P21–P24: 0.083
P25–P28: 0.016
In vitro, submerged, LTP P13–P14: WT: 10(2),
KO: 7(2)
P21–P24: WT: 15(2),
KO: 14(2)
P25–P28: WT: 15(3),
KO: 20(3)
Over age groups:
ANOVA
WT: 0.012, KO: 0.77 P13–P14: WT: 51.6 (12.9),
KO: 61.6 (11.4)
P21–P24: WT: 44.6 (7.9),
KO: 58.2 (13.2)
P25–P28: WT: 30.5 (8.2),
KO: 55.3 (7.8)
Between genotypes:
Student’s t test
P13–P14: 0.30
P21–P24: 0.09
P25–P28: 0.0002
*Median and percentiles [25th 75th] are reported for nonparametric datasets instead of mean and CI values.
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(N  15); KO, 33  13% (N  16); p  0.0001 in a
two-way ANOVA; Fig. 2A]. Further corroborating our in
vitro results, basal synaptic transmission was significantly
decreased in Shank2 ex7/mice versus wild-type con-
trols when assessed in awake, behaving animals (Fig. 2C).
In summary, we observe enhanced LTP and reduced
synaptic basal transmission in Shank2 ex7/ mice un-
der a range of different conditions both in vitro and in vivo.
In contrast to Shank2 ex7/mice, Shank2 ex6-7/
mice have been reported to show decreased LTP in vitro
(Won et al., 2012; Peter et al., 2016), and genetic differ-
ences between the two mouse models have been sug-
gested to account for this discrepancy (Lim et al., 2017).
However, a direct comparison of excitatory synaptic
transmission in the two models has so far been lacking.
Thus, we next investigated in vivo LTP in freely behaving
Shank2 ex6-7/ mice. Both short- and long-lasting
forms of LTP could be induced in wild-type as well as
knock-out mice, with no significant difference in the mag-
nitude of LTP expression (Fig. 3). A trend toward reduced
short-lasting LTP in Shank2 ex6-7/ mice was not
stable over time (2h-LTP: WT, 12 10% (N 10); KO, 11
7% (N  10); p  0.16 in a two-way ANOVA; Fig. 3B),
although it was reminiscent of in vitro observations made by
other laboratories (Won et al., 2012; Peter et al., 2016).
How can we understand the phenomena of reduced
synaptic transmission and increased LTP in Shank2
ex7/ mice? Is there a mechanistic explanation linking
these two findings? In Shank3/ mice, reduced LTP has
been associated with NMDA as well as AMPA receptor
hypofunction (Wang et al., 2011; Kouser et al., 2013). Both
mechanisms seem possible, since hippocampal CA1 LTP
is dependent on both NMDA and AMPA receptors in its
induction and expression, respectively (Nicoll, 2017).
Shank2 ex7/ mice show reduced AMPA receptor-
dependent basal synaptic transmission (Fig. 1C), and, in
submerged stored slices, a reduction in AMPA/NMDA
ratios (Fig. 1D). In Drosophila melanogaster, animals lack-
ing all SHANK isoforms show synaptic maturation deficits
at the glutamatergic neuromuscular junction (Harris et al.
2016). We thus set out to test whether synapses lacking
SHANK2 might possess fewer AMPA receptors or be
functionally silent by lacking them altogether, rendering
these synapses salient LTP substrates. To estimate the
fraction of silent synapses, we performed minimal stimu-
lation experiments. For each set of stimulated synapses,
we recorded EPSCs at a holding potential of 60 mV
(conducted by AMPA receptor-containing synapses) and
at 40 mV, when synapses lacking AMPA receptors but
harboring NMDA receptors can also pass currents. In-
deed, minimal stimulation revealed markedly higher failure
rates (rf) in Shank2 ex7
/ mice than in wild-type con-
trols at60 mV but not at40 mV [rf60mV: WT, 16 3%;
KO, 36  6%; rf40mV: WT, 13  3%; KO, 13  2%;
N/  11(6), N/  14(6); Fig. 4A], corresponding to a
fraction of 	51% silent synapses in knock-out mice,
compared with 	11% in wild-type controls. We next
compared the transmission strength of individual syn-
apses between Shank2 ex7/mice and wild-type mice.
To that end, we expressed the apparent synaptic potency
S (the average amplitude of successfully evoked EPSCs)
as a function of the observed failure rate rf (which relates
to the number of potentially active synapses) and fitted
the mean quantal size q with p   ln rf * q (for details,
see Materials and Methods). The average synaptic re-
sponse estimated from this relationship was not different
between Shank2 ex7/ and wild-type mice for either
NMDA receptor-mediated or AMPA receptor-mediated
events (mean  CI; qNMDA: WT, 4.4  0.4 pA; KO, 4.3 
0.5 pA; qAMPA: WT, 9.7  2.7 pA; KO, 8.8  3.1 pA;
Fig. 4B). This suggests that it is mainly the higher difference
in failure rates in Shank2ex7/mice (Fig. 4C), and thus an
excess of silent synapses, that accounts for the reduced
AMPA/NMDA receptor ratio of the knockout (Fig. 4D).
It is conceivable that the increased fraction of silent
synapses in Shank2 ex7/ mice provides the structural
framework for the increased LTP. To investigate how the
two phenomena are correlated through maturation of the
hippocampal circuitry, we repeated minimal stimulation
and LTP experiments in juvenile mice [postnatal day 13
(P13) to P14]. At that age, wild-type and Shank2 ex7/
mice alike showed high failure rates at hyperpolarized
holding potentials and, consequently, a high fraction of
silent synapses [silent synapses: WT, 	48%; KO, 	52%;
rf at 60 mV: WT, 43  6%; KO, 42  6%; rf at 40 mV:
WT, 19  2%; KO, 17  2%; N/  16(7), N/  18(7);
t test over difference in failure rates between genotypes, p
 0.76]. Within the same age range, the magnitude of LTP
evoked through tetanic stimulation was comparably high
in both genotypes [WT, 52  7%; KO, 62  6%; N/ 
10(2); N/  7(2); p  0.3, Student’s t test], and AMPA/
NMDA ratios were comparably low [WT, 0.71  0.08; KO,
0.55  0.08; N/  16(7); N/  18(7); p  0.055,
Mann–Whitney U test]. From P13 to P28, we saw signifi-
cant synaptic maturation in juvenile wild-type mice (LTP,
p 0.01, ANOVA; AMPA/NMDA ratios, p 0.003, Kruskal-
Wallis) that was virtually absent in Shank2 ex7/ mice
(LTP, p  0.77, ANOVA; AMPA/NMDA ratios, p  0.06,
Kruskal–Wallis test; Fig. 4E). We thus propose the deficient
maturation of excitatory synapses in Shank2 ex7/ mice
as a possible cause for their decreased synaptic basal trans-
mission, their decreased AMPA/NMDA ratios, and their in-
creased capacity for LTP.
Discussion
In summary, we consistently observe increased LTP in
hippocampal Schaffer collateral–CA1 synapses of Shank2
ex7/ mice in vitro as well as in awake behaving ani-
mals. We have further uncovered a developmental syn-
apse phenotype, an excess of silent synapses, that could
link the phenomena of decreased synaptic transmission
and increased LTP. During LTP expression, synaptic
strength increases with the incorporation of AMPA recep-
tors, a process through which immature, silent synapses
(that previously lacked such receptors) can become un-
silenced (Isaac et al., 1995; Liao et al., 1995; Durand et al.,
1996). The idea that an increase in the number of silent
synapses could provide a structural platform for the incor-
poration of additional AMPA receptors and hence a boost in
LTP expression is corroborated by similar observations in
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CamKIV/ mice acutely expressing constitutively active
CamKIV variants (Marie et al., 2005) and observations in
PSD95/ mice (Huang et al. 2015). A selective decrease in
the number, but not the strength, of mature (AMPA receptor-
containing) synapses is in good agreement with the results
of a recent study on the effects of lentiviral-mediated
SHANK2 knockdown in hippocampal slice culture (Shi et al.,
2017) and relates to the reduction in frequency, but not
amplitude, of spontaneously occurring mEPSCs in Shank2
ex7/ mice (Schmeisser et al., 2012).
Why synaptic transmission is weak in Shank2 ex7/
mice, although LTP can readily be induced in vitro and in
vivo, remains to be elucidated. Similar observations have
been made, however, upon acute knockdown of PSD-95
in hippocampal slice cultures (Ehrlich et al., 2007). It is
conceivable that the loss of SHANK2 may be a reason for
decreased synaptic stability (Stanika et al., 2015) or the
failure to instruct concomitant structural changes in po-
tentiated synapses along with the early insertion of AMPA
receptors (MacGillavry et al., 2016). Another open ques-
tion is why, in our hands, AMPA/NMDA ratios in wild-type
versus knockout animals are dependent on slice storage
conditions. It is tempting to speculate that the hyperplas-
ticity of synapses in Shank2 ex7/mice could influence
their recovery after slice preparation.
At first sight, it seems peculiar that the Shank2 ex7/
mouse line stands alone with its phenotype of increased
LTP, while mouse lines with mutations in other Shank
homologs show either no change in synaptic plasticity
(Shank1, Hung et al., 2008) or reduced LTP (Shank3,
Bozdagi et al., 2010; Kouser et al., 2013). However, con-
sidering the vast body of literature on isoform-specific
Figure 4. Minimal stimulation reveals insufficiently matured synapses in Shank2 ex7/ mice. A, EPSCs were recorded at
different holding potentials under minimal stimulation in vitro. Failure rates are plotted for control (left) and Shank2 ex7/ mice
(right). p  0.0003 [paired Student’s t test. Example traces at top (top, EPSCs recorded at 40 mV; bottom, EPSCs recorded
at 60 mV). B, For each holding potential, the apparent synaptic potency S (the average amplitude of all EPSCs) is expressed
as a function of the failure rate rf. Circles, line, and shaded area in black and red represent individual experiments, best fit, and
the 95% confidence interval for wild-type and Shank2 ex7/ mice, respectively (for details, see Materials and Methods). C,
The respective difference between failure rates at hyperpolarized vs depolarized potentials (rf 60mV  rf 40mV) is significantly higher in
Shank2 ex7/ mice than in wild-type controls. p  0.0018 (Student’s t test. D, AMPA/NMDA receptor ratios calculated from the
average EPSC of minimal stimulation experiments are smaller in Shank2 ex7/ mice than in wild-type controls (average is
calculated across successes and failures alike). p  0.036 Mann–Whitney U test. E, Synaptic maturation in wild-type (black) and
Shank2 ex7/ mice (red) assessed in juvenile (P13–P14) and adolescent mice (P21–P28). Box plots (dashed) show AMPA/NMDA
ratios from minimal stimulation experiments (left axis); mean and SE (nondashed) show LTP magnitude after tetanic stimulation (right
axis). Significant differences can first be detected in mice aged P25–P28 (AMPA/NMDA ratios, p  0.016, Mann–Whitney U test; LTP,
p  0.0002, Student’s t test).
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expression (Lim et al., 1999); protein–protein interactions
(Lim et al., 2001; Boeckers et al., 2005); and spatiotem-
poral localization of SHANK1, SHANK2, and SHANK3
(Böckers et al., 2004; Grabrucker et al., 2011), different
phenotypes in mutants lacking different isoforms are
not surprising (Shi et al., 2017) and may in fact be
indicators of isoform-specific functions of SHANK pro-
teins in synapse formation, development, and plasticity.
Of note, Shank2 ex6-7/ mice (Won et al., 2012) do
not show increased in vivo LTP in our hands, in contrast to
Shank2 ex7/ mice. This difference between the two
models is in line with earlier reports on their excitatory
synaptic transmission (Schmeisser et al., 2012; Won et al.,
2012) and parallels differences in their GABAergic physi-
ology (Lim et al., 2017). When comparing these two
Shank2 knockout mouse lines, isoform-specific differ-
ences in protein function fall short of explaining pheno-
typic differences, since both knockouts are null mutants
on the SHANK protein level (Schmeisser et al., 2012; Won
et al., 2012). The two mouse models exhibit differences in
their genetic background, however, manifest in the differ-
ential expression of numerous genes (Lim et al., 2017).
Resultant genetic interactions could be partly responsible
for phenotypic variations and are in line with the supposed
existence of “modifier genes” in the pathophysiology and
etiology of ASDs (Leblond et al., 2012).
Shank2 ex7/ mice reproduce several phenotypes
associated with ASDs, a neurodevelopmental disorder
(Schmeisser et al., 2012; Won et al., 2012; Ko et al., 2016).
In this context, it is interesting that we have uncovered an
unexpected neurodevelopmental phenotype in Shank2
ex7/ mice: defective synapse maturation. A similar
excess of silent synapses has been described in mice
lacking Sapap3 (Wan et al., 2011), a GKAP family protein
that directly interacts with SHANKs (Boeckers et al., 1999;
Naisbitt et al., 1999; Yao et al., 1999). Of note, the loss of
Sapap3 causes obsessive-compulsive behavioral traits in
mice (Welch et al., 2007), which are typical in individuals
with autism and have also been described in Shank2
ex7/ mice (Schmeisser et al., 2012). Likewise,
FMR1/ mice, a model for the autism-related fragile X
syndrome, show altered plasticity and synapse matura-
tion in the barrel cortex (Harlow et al., 2010). Last, in a
mouse line with SYNGAP1 haploinsufficiency, a genetic
model for intellectual disability and ASDs, hippocampal
synapses are unsilenced prematurely, adversely impact-
ing learning and memory in the adult animal (Rumbaugh
et al., 2006; Clement et al., 2012). Together with the
present findings, these studies draw a picture of synapse
maturation as a tightly controlled process, the dysregulation
of which seems of relevance for a range of neurodevelop-
mental disorders; the process of synaptic maturation should
therefore be investigated further in future studies, in partic-
ular with regard to how it can be influenced by therapeutic
approaches.
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